Established 1999
 
8,000 companies from
USA,Canada and India.		  
   
Search over 25,000 News & Earnings Archives    
 

Penwest Pharmaceuticals Co.(PPCO)

 
123Jump Rating:   Underwriters: BancBoston
      SBC Warburg Dillon Read Inc.
Status:  
 
Address: 2981 Route 22
 FiledDate:
     
  Filed Price Range ($):
       
Telephone: (914) 878-3414 Filed Offer Amount ($ Million): $0.00
       
Fax: Shares Offered (Millions): 2,500,000
       
Websites: Shares Outstanding (Millions): 17,038,282
       
Management: Tod R. Hamachek, Chairman/CEO
 IPO Date:
  John V. Talley, Jr., President/COO
    
  Jennifer L. Good, VP/CFO
 Final Offer Price ($): $0.00
       
Industry: Final Offer Size (Millions of Shares): 0.00
       
Employees: 118 Final Offer Amount ($ Million): $0.00
       
Competitors: Jago Pharma AG
 S-1 Forms:
  Elan Corporation International
    
  Biovail Corporation International
  
       
     
     
     
       
 
- Avoid        - Value Gap        - Short-Term Growth        - Long-Term Growth        - Long-Term Value

Income Data 
Year Revenues Costs Oper Income Taxes Net Income EPS
1992 19406 13114 0.00 0.00 339 .02
1993 21355 13708 0.00 0.00 8 0.00
1994 23146 15910 -2107 522 -2629 .18
1995 25089 17267 -2573 679 -3252 -.22
1996 26089 18690 -3100 764 -3864 -.27
1997 20787 14660 -2614 561 -3175 -.22
* Nine months ended September 30, 1997
 
 
350 Fund Managers Interviews - 10-year Annual earnings on 4,600 U.S. companies - 20-quarter Earnings on 3,800 U.S. companies - 3,200 U.S. IPO Prospectuses
- 2,100 Economic data releases from U.S., EU, UK, India, HK and Australia. 10-year Annual reports on 3,500 U.S. companies -
U.S. Earnings Calendar with 4,800 companies - 90,000 10-K reports - 26,000 Global markets news archive - 2,200 Earnings Conference Call Summaries
© 1999-2008 123jump.com. All rights reserved